Privately-owned Biocartis SA of Switzerland and bioMerieux of France have entered into a strategic collaboration to co-develop assays for use in a number of healthcare-associated infections, sepsis and oncology. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
